Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-046162
Filing Date
2025-03-27
Accepted
2025-03-27 16:48:18
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 kytx_s-3_march_2025.htm S-3 873554
2 EX-1.2 kytx-ex1_2.htm EX-1.2 350084
3 EX-4.2 kytx-ex4_2.htm EX-4.2 718323
4 EX-5.1 kytx-ex5_1.htm EX-5.1 68245
5 EX-23.1 kytx-ex23_1.htm EX-23.1 4031
6 EX-FILING FEES kytx-exfiling_fees.htm EX-FILING FEES 103084
7 GRAPHIC img89746796_0.jpg GRAPHIC 28888
8 GRAPHIC img89746796_1.jpg GRAPHIC 11290
9 GRAPHIC img220729232_0.jpg GRAPHIC 55411
10 GRAPHIC img220729232_1.jpg GRAPHIC 139443
11 GRAPHIC img220729232_2.jpg GRAPHIC 55411
12 GRAPHIC img220729232_3.jpg GRAPHIC 139443
13 GRAPHIC img220729232_4.jpg GRAPHIC 55411
  Complete submission text file 0000950170-25-046162.txt   2787742
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286180 | Film No.: 25780126
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)